434 related articles for article (PubMed ID: 25644981)
1. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
Tang X; Holland D; Dale AM; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
[TBL] [Abstract][Full Text] [Related]
2. Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.
Tang X; Holland D; Dale AM; Younes L; Miller MI;
Hum Brain Mapp; 2014 Aug; 35(8):3701-25. PubMed ID: 24443091
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal and Amygdalar Morphological Abnormalities in Alzheimer's Disease Based on Three Chinese MRI Datasets.
Wei Y; Huang N; Liu Y; Zhang X; Wang S; Tang X
Curr Alzheimer Res; 2020; 17(13):1221-1231. PubMed ID: 33602087
[TBL] [Abstract][Full Text] [Related]
4. Baseline shape diffeomorphometry patterns of subcortical and ventricular structures in predicting conversion of mild cognitive impairment to Alzheimer's disease.
Tang X; Holland D; Dale AM; Younes L; Miller MI
J Alzheimers Dis; 2015; 44(2):599-611. PubMed ID: 25318546
[TBL] [Abstract][Full Text] [Related]
5. APOE Affects the Volume and Shape of the Amygdala and the Hippocampus in Mild Cognitive Impairment and Alzheimer's Disease: Age Matters.
Tang X; Holland D; Dale AM; Miller MI;
J Alzheimers Dis; 2015; 47(3):645-60. PubMed ID: 26401700
[TBL] [Abstract][Full Text] [Related]
6. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
Qu H; Ge H; Wang L; Wang W; Hu C
Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
[TBL] [Abstract][Full Text] [Related]
7. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
Madusanka N; Choi HK; So JH; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
[TBL] [Abstract][Full Text] [Related]
8. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
Wang N; Zhang L; Yang H; Luo X; Fan G
Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
[TBL] [Abstract][Full Text] [Related]
9. Early amygdala and ERC atrophy linked to 3D reconstruction of rostral neurofibrillary tau tangle pathology in Alzheimer's disease.
Stouffer KM; Chen C; Kulason S; Xu E; Witter MP; Ceritoglu C; Albert MS; Mori S; Troncoso J; Tward DJ; Miller MI;
Neuroimage Clin; 2023; 38():103374. PubMed ID: 36934675
[TBL] [Abstract][Full Text] [Related]
10. Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort.
Miller MI; Younes L; Ratnanather JT; Brown T; Trinh H; Lee DS; Tward D; Mahon PB; Mori S; Albert M;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S3-S10. PubMed ID: 25444602
[TBL] [Abstract][Full Text] [Related]
11. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
He P; Qu H; Cai M; Liu W; Gu X; Ma Q
Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
[TBL] [Abstract][Full Text] [Related]
12. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
Josephs KA; Dickson DW; Tosakulwong N; Weigand SD; Murray ME; Petrucelli L; Liesinger AM; Senjem ML; Spychalla AJ; Knopman DS; Parisi JE; Petersen RC; Jack CR; Whitwell JL
Lancet Neurol; 2017 Nov; 16(11):917-924. PubMed ID: 28919059
[TBL] [Abstract][Full Text] [Related]
13. Geodesic distance on a Grassmannian for monitoring the progression of Alzheimer's disease.
Gui L; Tang X; Moura JMF
Neuroimage; 2017 Feb; 146():1016-1024. PubMed ID: 27756616
[TBL] [Abstract][Full Text] [Related]
14. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
15. Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.
Soldan A; Pettigrew C; Lu Y; Wang MC; Selnes O; Albert M; Brown T; Ratnanather JT; Younes L; Miller MI;
Hum Brain Mapp; 2015 Jul; 36(7):2826-41. PubMed ID: 25879865
[TBL] [Abstract][Full Text] [Related]
16. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
17. Non-linear registration improves statistical power to detect hippocampal atrophy in aging and dementia.
Bartel F; Visser M; de Ruiter M; Belderbos J; Barkhof F; Vrenken H; de Munck JC; van Herk M;
Neuroimage Clin; 2019; 23():101902. PubMed ID: 31233953
[TBL] [Abstract][Full Text] [Related]
18. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Dinov ID; Dutton RA; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Brain; 2006 Nov; 129(Pt 11):2867-73. PubMed ID: 17018552
[TBL] [Abstract][Full Text] [Related]
19. Ventricular enlargement and its clinical correlates in the imaging cohort from the ADCS MCI donepezil/vitamin E study.
Apostolova LG; Babakchanian S; Hwang KS; Green AE; Zlatev D; Chou YY; DeCarli C; Jack CR; Petersen RC; Aisen PS; Cummings JL; Toga AW; Thompson PM
Alzheimer Dis Assoc Disord; 2013; 27(2):174-81. PubMed ID: 23694947
[TBL] [Abstract][Full Text] [Related]
20. Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease.
Younes L; Albert M; Miller MI;
Neuroimage Clin; 2014; 5():178-87. PubMed ID: 25101236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
